Recent progress in H₂S activated diagnosis and treatment agents

Area of Science:

• Biochemistry
• Medical Diagnostics
• Therapeutics

Background:

• Hydrogen sulfide (H₂S) acts as a crucial endogenous signaling molecule regulating physiological processes like vascular tone and neuromodulation.
• Aberrant H₂S levels are implicated in various diseases, necessitating precise in vivo monitoring.
• Traditional H₂S detection methods struggle with its volatility and rapid metabolism, limiting real-time in vivo applications.

Purpose of the Study:

• To review recent advancements in H₂S detection probes for both in vitro and in vivo applications.
• To explore the development of H₂S-activated therapeutic agents for targeted cancer treatment.
• To highlight the potential of optical probes in overcoming limitations of conventional H₂S detection methods.

Main Methods:

• Review of literature on optical probes for H₂S detection.
• Analysis of studies on H₂S-activated agents for cancer therapy.
• Discussion of the advantages of optical probes: sensitivity, rapid response, non-invasiveness, and real-time monitoring capabilities.

Main Results:

• Optical probes offer superior sensitivity, speed, and non-invasive capabilities for real-time H₂S detection in vitro and in vivo.
• H₂S-activated agents show promise for colon cancer treatment, minimizing side effects on normal tissues.
• These advancements facilitate a deeper understanding of H₂S roles in health and disease.

Conclusions:

• Optical probes represent a significant breakthrough for in vivo H₂S monitoring, addressing limitations of traditional methods.
• H₂S-activated therapies offer a promising, targeted approach to cancer treatment with reduced toxicity.
• Further research in H₂S detection and targeted therapies holds potential for improved diagnostics and patient outcomes.